Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Bode Technology and Gene By Gene Receive New York State Department of Health Approval to Perform Forensic Genetic Genealogy

Combined solutions from both companies will enable law enforcement to solve cold cases


News provided by

Bode Technology

May 12, 2021, 14:25 ET

Share this article

Share toX

Share this article

Share toX


LORTON, Va., May 12, 2021 /PRNewswire-PRWeb/ -- Bode Technology (Bode), a leading provider of forensic DNA services, and Gene By Gene, a leader in genetic testing and owners of the FamilyTreeDNA database, announce approval of a combined solution to provide Forensic Genealogy Services (FGS) in New York. For the first time, these services are approved by the New York Department of Health and available to law enforcement, attorneys and innocence networks. The service offering creates a powerful investigative tool, joining Bode's forensic experience with Gene By Gene's advanced SNP testing and the FamilyTreeDNA database.

Forensic genetic genealogy originally gained publicity after the identification of the Golden State Killer. Since then, hundreds of cold case homicides and unidentified remains, previously thought to be unsolvable, have new investigative leads as a result of this technology. Bode and Gene By Gene have partnered on many of these cases including the arrest of an accused serial rapist (Durham, NC), serial rapists in CT, and the identification of a suspect in a decades-old cold case homicide (Portland, OR). Forensic genealogy has also provided new information in post-conviction cases.

Bode has a long history of providing forensic support in New York and we are excited to be able to offer forensic genealogy to help solve cold cases throughout the state.

Post this

"Bode has a long history of providing forensic support in New York and we are excited to be able to offer forensic genealogy to help solve cold cases throughout the state," said Mike Cariola, President and CEO of Bode Technology. "Most of our forensic genealogy cases include challenging evidence and require our advanced DNA sampling and extraction methods."

Bode has performed DNA testing on thousands of samples in New York, including more than 15,000 sexual assault kits and more than 20,000 unidentified remains from the World Trade Center attack. Through these efforts, Bode developed proprietary technologies to obtain DNA from challenging samples and degraded remains. Gene By Gene has been Bode's primary partner for the SNP testing required for forensic genealogy testing and a significant majority of the investigative leads developed to date have been generated from the FamilyTreeDNA database.

"We have seen first-hand the incredible positive impact the FamilyTreeDNA database has in improving public safety and the closure it has provided for victims of crime," said Connie Bormans, Laboratory Director of Gene By Gene. "The use of forensic genealogy has provided closure for families that have been seeking answers for decades. We encourage more citizens to join us as we continue to solve these cases."

Through the FamilyTreeDNA database, investigators can upload unknown profiles from violent crimes such as homicides, rapes, and unidentified remains. To date, hundreds of investigative leads have been provided to law enforcement in cases previously thought of as unsolvable.

Bode and Gene By Gene both offer high-quality and accredited services. The shared focus on quality and responsible implementation of this technology enabled the combined solution to be approved for use throughout the state of New York.

About Bode Technology

Bode operates one of the most internationally respected private forensic DNA laboratories and provides a comprehensive set of state-of-the-art forensic DNA collection products, DNA analysis services, and research services to law enforcement, the justice system and other government agencies around the world. Bode is accredited by ANSI National Accreditation Board (ANAB) to ISO/IEC 17025:2017 for Forensic Testing and Calibration Laboratories. Bode also maintains compliance with the FBI Quality Assurance Standards for Forensic DNA Testing Laboratories and DNA Databasing Laboratories. Bode also maintains AABB accreditation for relationship testing and holds a CLIA certification for diagnostic testing.

About FamilyTreeDNA and Gene By Gene

Founded in 2000, FamilyTreeDNA is the pioneer of the genetic genealogy and direct-to-consumer DNA testing industry, and the top choice for consumer privacy, according to U.S. News and World Report and Consumer Report. FTDNA is a privately held company located in Houston, Texas. http://www.familytreedna.com. Gene By Gene is a CAP and CLIA accredited laboratory located in Houston, Texas which processes genetic tests for commercial customers, along with consumer DNA tests for its FamilyTreeDNA division. http://www.genebygene.com.

Media Contact

Andrew Singer, Bode Technology, +1 703.646.9888, [email protected]

Media Contact, Gene By Gene, [email protected]

Twitter, Facebook

SOURCE Bode Technology

Related Links

https://www.bodetech.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.